To view the PDF file, sign up for a MySharenet subscription.
Back to DCP SENS
DIS-CHEM:  3,168   +35 (+1.12%)  20/06/2025 19:00

DIS-CHEM PHARMACIES LIMITED - Announcement Relating To The Restructuring Of Share Portfolio, Directors Dealing And Changes In Beneficial Interest

Release Date: 20/06/2025 17:05
Code(s): DCP     PDF:  
Wrap Text
Announcement Relating To The Restructuring Of Share Portfolio, Director’s Dealing And Changes In Beneficial Interest

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE securities code: DCP
ISIN: ZAE000227831
("Dis-Chem" or "the Company")

ANNOUNCEMENT RELATING TO THE RESTRUCTURING OF SHARE PORTFOLIO, DIRECTOR'S DEALING
AND CHANGES IN BENEFICIAL INTEREST

Shareholders are hereby advised that Mr Ivan Saltzman is in the process of restructuring his interest in
the Dis-Chem share portfolio which is held through Ivlyn Local Investment Holdings Proprietary Limited.
This restructuring involves the distribution 217 125 386 ordinary shares. All distributed shares will remain
within the Saltzman family, thereby continuing current family ownership.

The transaction will not affect the liquidity of the Company's shares traded on the Johannesburg Stock
Exchange ("JSE").

In compliance with sections 3.63 to 3.74 of the JSE Listings Requirements, the following information is
disclosed:

Name of director:                Ivan Saltzman
Name of associate:               Ivlyn Local Investment Holdings Proprietary Limited (Ivlyn)
Class of securities:             Ordinary shares
Number of securities:            217 125 386
Price per security:              Nil
Deemed value of transaction:     R 6 802 538 343 (based on the 19th of June 2025 closing price)
Date of transaction:             20th of June 2025
Nature and extent of interest:   Indirect beneficial

Clearance for the above transaction was obtained in accordance with Dis-Chem's share dealings policy.


CHANGE IN BENEFICIAL INTEREST

In compliance with Section 122(3)(b) of the Companies Act, 2008 (Act 71 of 2008), as amended
("Companies Act") and paragraph 3.83(b) of the Listings Requirements of the JSE, shareholders are
advised that Ivlyn has distributed a beneficial interest in the securities of the Company, such that the total
interest in the ordinary shares of the company held by Ivlyn amounts to 4,06% (previously held 29.31% of
the total number of securities in issue).

Mr Dan Saltzman and Mr Mark Saltzman individually now own a beneficial interest in the Company of
12,62% (previously 0,00%).

As required in terms of section 122(3) (a) of the Companies Act, Dis-Chem has filed the required notice
with the Takeover Regulation Panel.

The Board of directors accepts responsibility for the information contained in this announcement having
relied on the information provided to it in the Form TRP 121.1 and certifies that, to the best of its
knowledge and belief, the information contained in this announcement is true and this announcement
does not omit anything that is likely to affect the import of such information.


Nikki Lumley
Company Secretary

Midrand
20 June 2025

Sponsor
The Standard Bank of South Africa Limited

Date: 20-06-2025 05:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.